Home > National Drug Code (NDC) > pioglitazone hydrochloride

pioglitazone hydrochloride - 51991-709-33 - (pioglitazone hydrochloride)

Alphabetical Index


Drug Information of pioglitazone hydrochloride

Product NDC: 51991-709
Proprietary Name: pioglitazone hydrochloride
Non Proprietary Name: pioglitazone hydrochloride
Active Ingredient(s): 30    mg/1 & nbsp;   pioglitazone hydrochloride
Administration Route(s): ORAL
Dosage Form(s): TABLET
Coding System: National Drug Codes(NDC)

Labeler Information of pioglitazone hydrochloride

Product NDC: 51991-709
Labeler Name: Breckenridge Pharmaceutical, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA078472
Marketing Category: ANDA
Start Marketing Date: 20130213

Package Information of pioglitazone hydrochloride

Package NDC: 51991-709-33
Package Description: 30 TABLET in 1 BOTTLE (51991-709-33)

NDC Information of pioglitazone hydrochloride

NDC Code 51991-709-33
Proprietary Name pioglitazone hydrochloride
Package Description 30 TABLET in 1 BOTTLE (51991-709-33)
Product NDC 51991-709
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name pioglitazone hydrochloride
Dosage Form Name TABLET
Route Name ORAL
Start Marketing Date 20130213
Marketing Category Name ANDA
Labeler Name Breckenridge Pharmaceutical, Inc.
Substance Name PIOGLITAZONE HYDROCHLORIDE
Strength Number 30
Strength Unit mg/1
Pharmaceutical Classes Peroxisome Proliferator Receptor alpha Agonist [EPC],Peroxisome Proliferator Receptor gamma Agonist [EPC],Peroxisome Proliferator-activated Receptor Activity [MoA],PPAR alpha [Chemical/Ingredient],PPAR gamma [Chemical/Ingredient],Thiazolidinedione [EPC],Thiazolidinediones [Chemical/Ingredient]

Complete Information of pioglitazone hydrochloride


General Information